Change to HbA1c Reporting

on Wednesday, 28 April 2021. Posted in Blood Sciences, Haematology, Biochemistry

In line with changes to guidelines for reporting and monitoring HbA1c levels, from the 1st June 2021, the HbA1c DCCT % result will no longer be reported, only the IFCC  mmol/mol result. This applies to any HbA1c test being processed at Heartlands, Good Hope or Solihull laboratories and will standardise reporting across the UHB laboratory network.

Leave a comment

Please login to leave a comment.

The laboratories at Heartlands Hospital, Good Hope Hospital and Solihull Hospital form part of the services provided by University Hospitals Birmingham and are UKAS (United Kingdom Accreditation Service) accredited to the ISO 15189:2012 standard. For a list of accredited tests and other information please visit the UKAS website using the following link: https://www.ukas.com/find-an-organisation/

  • Heartlands, Good Hope and Solihull Hospital pathology laboratories are a UKAS accredited medical laboratory No.8217
  • United Kingdom Health Security Agency laboratory is a UKAS accredited medical laboratory No.8213

Tests not appearing on the UKAS Schedule of Accreditation currently remain outside of our scope of accreditation. However, these tests have been validated to the same high standard as accredited tests and are performed by the same trained and competent staff.

For further test information, please visit the test database: http://www.heftpathology.com/frontpage/test-database.html.

For further information contact Louise Fallon, Quality Manager, 0121 424 1235

UKAS HEFT